Nitric oxide does not contribute to inflammation-induced hypoferremia in humans.
Kemna
Erwin H J M
EH
Department of Clinical Chemistry, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. e.kemna@akc.umcn.nl
Pickkers
Peter
P
Tjalsma
Harold
H
Swinkels
Dorine W
DW
D000293:Adolescent; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000097:blood* / Q000209:etiology / Q000652:urine*; D023181:Antimicrobial Cationic Peptides / Q000652:urine*; D016207:Cytokines / Q000097:blood; D019446:Endotoxemia / Q000097:blood* / Q000139:chemically induced / Q000150:complications / Q000652:urine*; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005260:Female; D006146:Guanidines / Q000008:administration & dosage; D064451:Hepcidins; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000139:chemically induced / Q000150:complications / Q000178:diet therapy / Q000652:urine; D007501:Iron / Q000097:blood*; D008070:Lipopolysaccharides / Q000633:toxicity; D008297:Male; D009569:Nitric Oxide / Q000097:blood*; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors / Q000378:metabolism
D023181:Antimicrobial Cationic Peptides; D016207:Cytokines; D004791:Enzyme Inhibitors; D006146:Guanidines; D064451:Hepcidins; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D007501:Iron; D052247:Nitric Oxide Synthase Type II; C004479:pimagedine